Cook County Record

Friday, February 21, 2020

LOCKE LORD LLP: Locke Lord Strengthens IP Biotech and Pharma Capabilities With Addition of Complex Patent Litigator Steven Trybus as Chicago Partner

By Press release submission | Oct 1, 2019


Locke Lord LLP issued the following announcement on Sept. 26.

Steven Trybu‎s, a veteran litigator who focuses on complex patent disputes, has joined Locke Lord’s Chicago office as a Partner in the Firm’s IP Pharmaceutical Practice Group. Trybus brings to Locke Lord a wealth of litigation experience across a variety of cutting-edge technologies in the fields of pharmaceuticals, biotechnology and life sciences.

Trybus is a distinguished lawyer in the defense of patents for the groundbreaking CRISPR gene-editing technology, which allows for the permanent modification of human, animal and plant genes to avoid, prevent or cure disease or undesirable traits. Trybus has also handled matters involving pharmaceuticals and medical devices; the chemical arts, such as polymers; electronics, including software and ‎telecommunications; and mechanical devices, such as food processing equipment.

“Steve is at the forefront of patent disputes for revolutionary technologies, including CRISPR, which will be integral to broadening our IP practice and reputation in Chicago and nationally,” said Keith Parr, Co-Chair of Locke Lord’s IP Pharmaceutical Practice Group and a Partner in the Firm’s Chicago office. “His technical skill adds strength to our already robust IP Pharma capabilities, and his arrival exhibits Locke Lord’s commitment to remaining a leading law firm for clients in the pharmaceutical industry, one of the Firm’s Key Sectors.”

Trybus, who joins Locke Lord from Jenner & Block, has more than 30 years of experience handling a wide range of patent infringement cases for both patent owners and accused infringers. He concentrates on patent litigation and related counseling with significant experience in contested proceedings in the U.S. Patent and Trademark Office. His practice includes interferences, inter partes reviews, post grant reviews and appeals.

“Locke Lord’s strong emphasis on life sciences including the pharmaceutical sector and highly regarded reputation made the Firm the ideal fit for collaboration and growth within my practice,” said Trybus. “With the support of a first-class team of lawyers renowned for its technical adeptness and experience across a variety of scientific fields, including chemistry and biotechnology, I will be able to significantly expand my client offerings. I am particularly eager to collaborate with the Firm’s esteemed life sciences lawyers in Boston and Providence, who have a history of skillfully serving innovative clients.”

Trybus has been recognized for his achievements as an Intellectual Property Trailblazer by the National Law Journal and an IP Star by Managing Intellectual Property. He is involved with the Federal Circuit Bar Association, the Intellectual Property Owners Association, the American Intellectual Property Law Association, the PTAB Bar Association, the American Association for the Advancement of Science, the American Chemical Society and the American Institute of Chemical Engineers.

Original source can be found here.

Want to get notified whenever we write about Locke Lord LLP ?

Sign-up Next time we write about Locke Lord LLP, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

Locke Lord LLP